A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome
Clinical trial NCT02334306 · COMPLETED
Trial details
- NCT number
- NCT02334306
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-08
- Primary completion
- 2018-01-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.